Live from the NIH registry
Studies recruiting near Wichita right now
Top 25 of 158 recruiting studies, sorted by proximity — each links to its official registry page
A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer
Non-Muscle Invasive Bladder Neoplasms
Phase 3
Interventional 641 participants sought
Wichita Urology Group — Wichita, Kansas (0.4 mi)
· Sponsor: Janssen Research & Development, LLC
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma
Phase 2
Interventional 40 participants sought
Ohio State University-Telemedicine — Wichita, Kansas (0.4 mi)
· Sponsor: Sameek Roychowdhury
Open-label, Long-term Safety, Efficacy, and Pharmacokinetics Study of Vibegron in Pediatric Subjects 2 Years to < 18 Years of Age With NDO and on CIC
Neurogenic Detrusor Overactivity
Phase 2, Phase 3
Interventional 71 participants sought
Wichita Urology Group — Wichita, Kansas (0.4 mi)
· Sponsor: Urovant Sciences GmbH
BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT
Hypertension, Hypertension, Systolic
N/A
Interventional 316 participants sought
Cardiovascular Research Institute of Kansas — Wichita, Kansas (0.4 mi)
· Sponsor: Orchestra BioMed, Inc
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Triple-Negative Breast Cancer
Phase 3
Interventional 1,530 participants sought
Cancer Center of Kansas ( Site 0004) — Wichita, Kansas (0.4 mi)
· Sponsor: Merck Sharp & Dohme LLC
Endurant Stent Graft System vs Excluder Endoprothesis: ADVANCE Trial
Abdominal Aortic Aneurysm, Abdominal Aortic Aneurysm >= 5.5 Centimeters in Male (Disorder)
N/A
Interventional 600 participants sought
Ascension Via Christi Saint Francis — Wichita, Kansas (0.4 mi)
· Sponsor: Medtronic Cardiovascular
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8
Phase 3
Interventional 1,209 participants sought
Ascension Via Christi Hospitals Wichita — Wichita, Kansas (0.4 mi)
· Sponsor: NRG Oncology
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Heart Failure With Preserved Ejection Fraction, Heart Failure With Mildly Reduced Ejection Fraction
Phase 3
Interventional 5,056 participants sought
Kansas Nephrology Research Institute LLC — Wichita, Kansas (0.4 mi)
· Sponsor: Amgen
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
Crohn Disease
Phase 2, Phase 3
Interventional 1,092 participants sought
Kansas Gastroenterology, LLC — Wichita, Kansas (0.4 mi)
· Sponsor: Janssen Research & Development, LLC
REGN7508 Versus Acetylsalicylic Acid (ASA) for Venous Thromboprophylaxis After Total Knee Arthroplasty in Adult Participants
Symptomatic Venous Thromboembolism (VTE)
Phase 3
Interventional 2,000 participants sought
NextStage Clinical Research, St. Francis Medical Park — Wichita, Kansas (0.4 mi)
· Sponsor: Regeneron Pharmaceuticals
HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes
Type 2 Diabetes
Phase 2
Interventional 300 participants sought
AMR Clinical - El Dorado — El Dorado, Kansas (27.8 mi)
· Sponsor: Housey Healthcare ULC
Pridopidine Phase 3 Study in Huntington's Disease
Huntington Disease
Phase 3
Interventional 400 participants sought
Hereditary Neurological Disease Centre — Wichita, Kansas (0.4 mi)
· Sponsor: Prilenia
Study to Learn More About the Safety and Effectiveness of the Drug VITRAKVI During Routine Use in Patients With TRK Fusion Cancer Which is Locally Advanced or Spread From the Place Where it Started to Other Places in the Body
Locally Advanced or Metastatic Solid Tumor Harboring an NTRK Gene Fusion
N/A
Observational 150 participants sought
Cancer Center of Kansas — Wichita, Kansas (0.4 mi)
· Sponsor: Bayer
REdo tranScatheter Aortic Valve Replacement for Transcatheter aOrtic Valve failuRE
Aortic Stenosis
N/A
Observational 225 participants sought
Ascension Via Christi St. Francis — Wichita, Kansas (0.4 mi)
· Sponsor: Medtronic Cardiovascular
Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
Obesity With Diabetes, Overweight With Diabetes
Phase 3
Interventional 1,156 participants sought
Kailera Clinical Site — Newton, Kansas (24.7 mi)
· Sponsor: Kailera
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
Obesity, Overweight
Phase 3
Interventional 1,100 participants sought
ACCOMPLISH-2 Research Site — Wichita, Kansas (0.4 mi)
· Sponsor: Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Stage I Breast Cancer
Phase 3
Interventional 1,670 participants sought
Cancer Center of Kansas-Wichita Medical Arts Tower — Wichita, Kansas (0.4 mi)
· Sponsor: NRG Oncology
Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes
Obesity
Phase 3
Interventional 1,200 participants sought
Kailera Clinical Site — Newton, Kansas (24.7 mi)
· Sponsor: Kailera
A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer
Prostate Cancer, Metastatic Castration Resistant Prostate Cancer
Phase 1
Interventional 174 participants sought
Wichita Urology Group — Wichita, Kansas (0.4 mi)
· Sponsor: Astellas Pharma Global Development, Inc.
EFS of the CardioMech MVRS
Mitral Regurgitation
N/A
Interventional 25 participants sought
Ascension St. Francis via Christi — Wichita, Kansas (0.4 mi)
· Sponsor: CardioMech AS
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
Heart Failure
Phase 3
Interventional 4,200 participants sought
Kansas Nephrology Research Institute, LLC — Wichita, Kansas (0.4 mi)
· Sponsor: Boehringer Ingelheim
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
End Stage Kidney Disease
Phase 2, Phase 3
Interventional 3,110 participants sought
Kansas Nephrology Physicians, PA — Wichita, Kansas (0.4 mi)
· Sponsor: CSL Behring
Safety and Effectiveness of the Orsiro Mission 48-mm Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions
Coronary Artery Disease
N/A
Interventional 150 participants sought
Ascension Via Christi Hospitals Wichita — Wichita, Kansas (0.4 mi)
· Sponsor: Teleflex
Evaluation of Enhanced Lithotripsy System (ELS) in the Treatment of Urinary Stones, A Pivotal Trial
Kidney Calculi; Ureteral Calculi
N/A
Interventional 101 participants sought
Wichita Urology Group — Wichita, Kansas (0.4 mi)
· Sponsor: Avvio Medical
Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort
Huntington's Disease
N/A
Observational 35,000 participants sought
Hereditary Neurological Disease Center — Wichita, Kansas (0.4 mi)
· Sponsor: CHDI Foundation, Inc.